Accelrys ~ Enterprise R&D Architecture

SAN DIEGOAccelrys Inc. (NASDAQ: ACCL) released the new Accelrys Enterprise R&D Architecture, designed to allow industries and organizations to bring new products from labs to market more quickly and efficiently. Through enhanced productivity, reduced costs, and improved quality and compliance across the value chain, the software is aimed at companies that rely on scientific innovation to create products.

Following the completion of integration with Symyx Technologies in July 2009, the Accelrys Enterprise R&D Architecture is designed to provide a broad, flexible solution that addresses the critical needs of scientists working in the life sciences, chemical, agro-science, consumer packaged goods, energy, aerospace and other industrial sectors.

Challenges associated with the R&D value chain constitute serious and costly obstacles for customers wishing to bring innovative products to market quickly," said Accelrys president and CEO Max Carnecchia. Todays technology often relies on proprietary, siloed technology that is time and process intensive, creating disconnected processes from research through early manufacturing. Our new Enterprise R&D Architecture addresses the breadth of scientific processes, domains and compliance challenges encountered across this value chain, speeding time to innovation. We are already actively engaged with customers who are implementing the architecture in novel ways."

The new Accelrys Enterprise R&D Architecture, using the Pipeline Pilot platform, offers configurable applications that can be tailored to integrate the diversity of science, experimental processes and information, and reporting requirements encountered across the research, development, process scale-up and early manufacturing phases of product development. The four key pillars of the Accelrys Enterprise R&D Architecture are: modeling and simulation, enterprise lab management, workflow definition and capture, and data management and informatics.  

R&D organizations today face numerous challenges in optimizing performance and productivity, ranging from disparate data issues to manually intensive, error-prone procedures to regulatory quagmires," said Dr. Alan S. Louie, research director, clinical development, strategy and technology with IDC Health Insights. The ability to effectively collect, analyze and share scientific data within an organization remains a differentiator that separates industry leaders from wannabes. In the race for R&D agility, the combined solution set created by the merger of Accelrys and Symyx is aligned with the critical need to help scientific organizations achieve this differentiation and reach their innovation goals."